
Aimee Pugh Bernard
-
Associate Professor of Immunology and Microbiology,
University of Colorado Anschutz Medical Campus
Dr. Aimee Pugh Bernard has a broad background in cellular immunology and molecular biology, with specific expertise in human immunology, having attained her PhD in the developmental regulation of human B cells and the autoimmune disorder Systemic Lupus Erythematosus (SLE). As a graduate student in immunology, Aimee studied the developmental regulation of VH4.34-expressing B cells as an experimental system for the study of human B cell tolerance. Her studies revealed that mechanisms of cellular regulation during development are impaired in patients with SLE leading to a breach in self-tolerance. As a post-doctoral fellow at National Jewish Health, her research focused on the phenotypic characterization of anergic human B cells via the analysis of basal calcium levels and the ability to flux calcium after stimulation. As a post-doctoral fellow at the Barbara Davis Center, her work revealed that Nkx2.2 is required in the differentiation of pancreatic beta cells and that insulin- and ghrelin-producing cells may share a common progenitor.
Aimee is an Associate Professor in the Department of Immunology and Microbiology at the University of Colorado Anschutz medical campus (CU AMC) and is actively involved in the CU School of Medicine (CUSOM) Trek curriculum reform, serving as the immunology content director. Aimee also teaches immunology within the medical school, graduate school, dental school, and the Child Health Advocate / Physician Assistant (CHA/PA) program on the Anschutz medical campus. At the start of the pandemic, Aimee helped to develop and run three courses for second, third and fourth year medical students that focused on the SARS-CoV-2 and COVID-19.
Aimee is dedicated to science communication and frequently delivers seminars and interactive sessions on immunology, vaccines, and science to a variety of audiences within the general public.
As a faculty mentor, she guides an amazing group of volunteer graduate students from all across campus to run a non-profit, after-school science program – Think Like a Scientist- at elementary schools throughout the Aurora and Denver communities.
In her role as the Assistant Director for the CU School of Medicine Dean's Office Human Immunology and Immunotherapy Initiative (HI3) Aimee has utilized her experience as an immunologist with expertise in human B cell development and autoimmunity, her skills as an educator and communicator of science, and her organizational and program building skills to coordinate the development of the research and clinical infrastructure necessary to create an all-inclusive, premier facility for the discovery and use of human immunotherapies for the treatment of cancer and autoimmune diseases.
Experience-
2019–present
Associate Professor of Immunology and Microbiology, University of Colorado Anschutz Medical Campus
University of Colorado School of Medicine Teaching Recognition Award 2024, Students Thanking and Recognizing (STAR) Outstanding Faculty Award 2023 (selected by CUSOM Class of 2026), University of Colorado Chase Faculty Community Service Award 2022


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Forex Expo Dubai 2025 Returns October 67 With Exclusive Prize Draw Including Jetour X70 FL
- Xfunded Expands In Dubai, Strengthening Collaborations With Trading Influencers Across Europe
- SPAYZ.Io White Paper Explores Opportunities, Challenges And Ambitions In Payments Industry
- B2BROKER Taps Finery Markets To Power Institutional Crypto OTC On B2TRADER
- Zebu Live 2025 Welcomes Coinbase, Solana, And Other Leaders Together For UK's Biggest Web3 Summit
- Daytrading Publishes New Study Showing 70% Of Viral Finance Tiktoks Are Misleading
Comments
No comment